Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Keratosis, Actinic 2Pituitary Neoplasms 1Pain 1Neoplasms 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1Lung Neoplasms 1Hemorrhage 1Haloperidol 1Growth Hormone-Secreting Pituitary Adenoma 1Brain Neoplasms 1Anemia 1Acromegaly 1

Interventions

Epoetin Alfa 27Darbepoetin alfa 13epoetin beta 3Erythropoietin 3telapristone acetate 2luspatercept 2ferric carboxymaltose 2Lenalidomide 2Ferric Oxide, Saccharated 2Cisplatin 2Blood Transfusion 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2ibrutinib 1fludarabine phosphate 1fludarabine 1ferrous sulfate 1ferric gluconate 1ferric derisomaltose 1fanasil, pyrimethamine drug combination 1Taxes 1Sugars 1Sucrose 1Solutions 1Saline Solution 1Rituximab 1Radiotherapy 1Pharmacogenomic Testing 1Paclitaxel 1Iron-Dextran Complex 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Anemia × Solutions × Clear all
NCT00711958 2017-09-05

Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer Patients

Sandoz

Phase 3 Completed
114 enrolled 10 charts
Classical hematology

Anemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡